Related Experiment Video
Updated: May 6, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 27, 2013
Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy
Sanjit S Jolly1, Stefan James2, Vladimír Džavík2
1From McMaster University and the Population Health Research Institute, Hamilton Health Sciences, Hamilton, ON, Canada (S.S.J., S.Y., P.G., A.A., B.M.); Department of Medical Science, Uppsala University and Uppsala Clinical Research Centre, Uppsala, Sweden (S.J., H.R., B.L.); Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada (V.D.); University of British Columbia, Vancouver, BC, Canada (J.A.C.); Department of Cardiology, Thorax Center, Erasmus Medical Centre, Rotterdam, the Netherlands (K.D.M., F.Z.); Skåne University Hospital-Lund/Lund University, Lund, Sweden (G.K.O.); University Clinic of Cardiology, Sts. Cyril and Methodius University, Skopje, Macedonia (S.K.); Clinical Center of Serbia and Department of Cardiology, Medical Faculty, University of Belgrade, Belgrade, Serbia (G.S.); and Örebro University, Faculty of Health, Department of Cardiology, Södra Grev Rosengatan, Örebro, Sweden (O.F.). sanjit.jolly@phri.ca.
Insights
Routine thrombus aspiration during percutaneous coronary intervention for ST-elevation myocardial infarction did not improve outcomes. In patients with high thrombus burden, aspiration showed trends toward reduced cardiovascular death but increased stroke risk.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Coronary Syndromes
Background:
- Thrombus aspiration is commonly used in percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI).
- Recent trials have raised questions about its efficacy and safety.
- This meta-analysis pooled individual patient data from major trials to re-evaluate its benefits and risks.
Purpose of the Study:
- To determine the benefits and risks of thrombus aspiration during PCI in STEMI patients.
- To analyze cardiovascular mortality and stroke/transient ischemic attack rates.
- To investigate outcomes in subgroups, particularly those with high thrombus burden.
Main Methods:
- Individual patient data meta-analysis of 3 large randomized controlled trials (TAPAS, TASTE, TOTAL).
- Included patients (n=18,306) undergoing PCI for STEMI.
- Primary outcomes: 30-day cardiovascular mortality and 30-day stroke/transient ischemic attack.
Main Results:
- No significant difference in 30-day cardiovascular death (2.4% vs 2.9%, P=0.06) or stroke/TIA (0.8% vs 0.5%, P=0.06) between thrombus aspiration and PCI alone.
- In the high thrombus burden subgroup, aspiration was linked to fewer deaths (P=0.03) but more strokes (P=0.04).
- No significant differences observed for recurrent MI, stent thrombosis, heart failure, or TVR.
Conclusions:
- Routine thrombus aspiration in STEMI PCI does not improve overall clinical outcomes.
- High thrombus burden patients showed trends suggesting potential benefit in mortality but increased stroke risk, warranting further investigation.
- Future trials could explore improved aspiration technologies for specific high-risk subgroups.
Background:
Thrombus aspiration during percutaneous coronary intervention (PCI) for the treatment of ST-segment-elevation myocardial infarction (STEMI) has been widely used; however, recent trials have questioned its value and safety. In this meta-analysis, we, the trial investigators, aimed to pool the individual patient data from these trials to determine the benefits and risks of thrombus aspiration during PCI in patients with ST-segment-elevation myocardial infarction.
Methods:
Included were large (n≥1000), randomized, controlled trials comparing manual thrombectomy and PCI alone in patients with ST-segment-elevation myocardial infarction. Individual patient data were provided by the leadership of each trial. The prespecified primary efficacy outcome was cardiovascular mortality within 30 days, and the primary safety outcome was stroke or transient ischemic attack within 30 days.
Results:
The 3 eligible randomized trials (TAPAS [Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Myocardial Infarction], TASTE [Thrombus Aspiration in ST-Elevation Myocardial Infarction in Scandinavia], and TOTAL [Trial of Routine Aspiration Thrombectomy With PCI Versus PCI Alone in Patients With STEMI]) enrolled 19 047 patients, of whom 18 306 underwent PCI and were included in the primary analysis. Cardiovascular death at 30 days occurred in 221 of 9155 patients (2.4%) randomized to thrombus aspiration and 262 of 9151 (2.9%) randomized to PCI alone (hazard ratio, 0.84; 95% confidence interval, 0.70-1.01; P=0.06). Stroke or transient ischemic attack occurred in 66 (0.8%) randomized to thrombus aspiration and 46 (0.5%) randomized to PCI alone (odds ratio, 1.43; 95% confidence interval, 0.98-2.10; P=0.06). There were no significant differences in recurrent myocardial infarction, stent thrombosis, heart failure, or target vessel revascularization. In the subgroup with high thrombus burden (TIMI [Thrombolysis in Myocardial Infarction] thrombus grade ≥3), thrombus aspiration was associated with fewer cardiovascular deaths (170 [2.5%] versus 205 [3.1%]; hazard ratio, 0.80; 95% confidence interval, 0.65-0.98; P=0.03) and with more strokes or transient ischemic attacks (55 [0.9%] versus 34 [0.5%]; odds ratio, 1.56; 95% confidence interval, 1.02-2.42, P=0.04). However, the interaction P values were 0.32 and 0.34, respectively.
Conclusions:
Routine thrombus aspiration during PCI for ST-segment-elevation myocardial infarction did not improve clinical outcomes. In the high thrombus burden group, the trends toward reduced cardiovascular death and increased stroke or transient ischemic attack provide a rationale for future trials of improved thrombus aspiration technologies in this high-risk subgroup.
Clinical Trial Registration:
URLs: http://www.ClinicalTrials.gov http://www.crd.york.ac.uk/prospero/. Unique identifiers: NCT02552407 and CRD42015025936.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

